Ameer Ally

Ameer Ally is the Senior Director of Healthcare Economics and Reimbursement at Covidien. He has more than 30 years of experience in the pharmaceutical and medical technology industries. He started his career in technical operations and regulatory affairs in the pharmaceutical industry and then moved into subsequent positions in the medical technology sector in regulatory affairs, government affairs, reimbursement and healthcare economics. Prior to Covidien he worked for Potters, American Cyanamid, Allergan and ConvaTec (a Bristol-Myers Squibb Company). Ameer has been an active worker in the UK medical technology trade associations and Eucomed and is currently the Chair Person of the Community Care Sector Group. He is a graduate in Biology, Medicinal and Pharmaceutical Chemistry and Law and has an MSc in Pharmaceutical Sciences. He lives in London and has a wife and four children.

Wound care
When most people think about chronic conditions, certain disease areas come to mind – diabetes, heart disease, obesity, asthma, allergies…the list goes on. However, it is unlikely that you think about chronic wounds as being part of that list. Why is that? Given that wounds impact 4 million Europeans per year (more than cancer and diabetes), it seems odd that so few people are aware of the impact on people, healthcare professionals and health budgets in Europe. For those who have heard about chronic wounds, it’s likely because a friend or relative has acquired a pressure ulcer in hospital, or had an infection after surgery, or maybe even faced foot amputation due to complications from diabetes. These wounds are often preventable with the right knowledge and treatment options available. A growing burden Yet, even though health systems are spending anywhere from 2 – 4% of healthcare expenditure on wounds, the burden of wounds continues to rise and will likely increase dramatically as the population ages and the incidence of diabetes grows. The average cost of a treating a wound is €6.000 – €10.000 per year and complications and readmission can significantly drive up costs (Gottrup et al. 2010). And on any given day in Europe, 27-50 % of acute hospital beds are likely to be occupied by patients with a wound (Posnett et al. 2009). So how can we reduce the burden of wounds on health systems? We can do it through smart investment in smart technologies. Because chronic wounds can cause multiple hospital readmissions and prevent individuals from working, EU Member States must begin to invest in solutions outside of acute settings that allow patients and healthcare professionals to prevent, treat and cure chronic wounds at home and in the community. Products and services such as Portable Negative Pressure...